SOCIETA' REGIONALE PER LA SANITA' SPA

Their core work

Società Regionale per la Sanità (So.Re.Sa.) is the regional health procurement and supply agency for the Campania region in southern Italy, responsible for centralizing the purchasing of healthcare goods, services, and technologies on behalf of the region's public hospitals and health authorities. In EU research projects, they contribute as a public procurer and "smart buyer" — providing the demand-side perspective essential for pre-commercial procurement (PCP) and public procurement of innovation (PPI) initiatives. Their participation spans both digital patient empowerment tools for chronic disease management and broader frameworks for procuring breakthrough healthcare innovations across European health systems. For consortium builders, they represent a real public health administration with procurement authority, making them a credible validation and implementation partner rather than a pure research actor.

What they specialise in

How they've shifted over time

With only two projects and no keywords attached to the earlier one (ProEmpower, 2016), a precise evolution is difficult to trace. The first project was oriented toward ICT and patient-facing tools for chronic disease, suggesting early involvement in digital health pilots. By 2019, the focus had clearly shifted to procurement methodology — PPI, PCP, MEAT criteria, value-based healthcare, and cross-border coordination — indicating a move from being a passive user of health technology to an active shaper of how public health systems buy it. This is a meaningful professional shift: from healthcare delivery participant to procurement policy actor.

So.Re.Sa. appears to be positioning itself as a reference public buyer for healthcare innovation, which makes them increasingly relevant for any consortium that needs a credible demand-side partner to validate or pilot new health technologies within a real regional procurement system.

How they like to work

So.Re.Sa. has participated exclusively as a consortium member, never as coordinator, across both of its H2020 projects. Despite minimal funding received (EUR 56,900 total), they have accumulated 36 unique partners across 13 countries — a disproportionately large network for their project count, which suggests they join large, well-connected consortia rather than small bilateral collaborations. Their value in these consortia is almost certainly their institutional role as a regional public buyer, not their research capacity.

So.Re.Sa. has engaged with 36 unique partners across 13 countries through just two projects, reflecting participation in large pan-European health consortia. Their network is European in scope, though their operational base and institutional mandate are anchored in the Campania region of Italy.

What sets them apart

So.Re.Sa. is not a research organization — it is a public procurement authority with an institutional mandate to buy healthcare goods and services for an entire Italian region. This makes them rare in EU consortia: they can commit real public purchasing power, not just research outputs. For any project that needs to demonstrate that an innovation can enter a public health system through formal procurement channels, So.Re.Sa. offers legitimacy that universities and private companies cannot replicate.

Highlights from their portfolio

• EURIPHI
  The largest and most thematically rich of their two projects, EURIPHI focused on European-wide innovative procurement of health innovation and covered a broad spectrum including rapid diagnostics, infectious disease, integrated care, and cross-border healthcare — making it the clearest expression of So.Re.Sa.'s institutional procurement expertise.
• ProEmpower
  Their earliest H2020 engagement, covering ICT tools for type 2 diabetes self-management, shows that So.Re.Sa. was involved in digital health pilots before shifting toward procurement policy — providing evidence of both patient-facing and system-level health technology experience.